Use of mullerian inhibiting substance as a contraceptive agent

Details Use of mullerian inhibiting substance as a contraceptive agent Use of mullerian inhibiting substance as a contraceptive agent

1986-06-24

1988-06-28

Kight, John

Drug, bio-affecting and body treating compositions

Lymphokine

424105, 514 8, 514841, 514843, 935106, 935107, A61K 3548, A61K 39395

Patent

active

047537949

ABSTRACT:
The invention discloses a novel use of Mullerian Inhibiting Substances (MIS) as a contraceptive agent. MIS has been found to inhibit the maturation of oocytes in vitro. Additionally, the invention provides a means for restoring the fertility of females who are infertile due to abnormal production of MIS.

REFERENCES:
patent: 4196265 (1980-07-01), Koprowski et al.
patent: 4404188 (1983-09-01), Donahoe et al.
patent: 4487833 (1984-12-01), Donahoe et al.
patent: 4510131 (1985-07-01), Donahoe et al.
Takahashi et al, CA, vol. 105(26), 1986, #184175b.
Takahashi et al., Chemical Abstracts, vol. 105, p. 90 (1986).
Takahashi et al., Molecular and Cellular Endocrinology, 47:225-234 (1986).
Blanchard et al., Pediat. Res. 8:968-971 (1974).
Donahoe et al., Biology of Reproduction, 15:329-334 (1976).
Donahoe et al., Journal of Pediatric Surgery, vol. 12, No. 3 (Jun.), 1977, pp. 323-330.
Donahoe et al., Biology of Reproduction, 16:238-243 (1977).
Budzik et al., Developmental Mechanisms: Normal and Abnormal, pp. 207-223 (1985).
Donahoe et al., Hybridoma, 3:201-214 (1984).
Vigier et al., Endocrinology, pp. 1315-1320 (1984).
Necklaws, Endocrinology, 118:791-796.
Donahoe et al., Science, 205:913-915, (1979).
Cate et al., Cell, 45:685-698 (1986).
Sato et al., Differentiation, 26:59-62 (1984).
Hillensjo et al., Role of Cumulus Cells in Oocyte Maturation, pp. 175-188.
Budzik et al., Cell, 21:909-915 (1980).
Budzik et al., Cell, 34:307-314 (1983).
Donahue, R., J. Exp. Zool., 169:237-250.
Donahoe et al., Ann. Surg., 472-480 (1981).
Hayashi et al., The Journal of Histochemistry and Cytochemistry, 32:649-654 (1984).
Picard et al., Biomedicine, 25:147-150 (1976).
Mudgett-Hunter et al., Federation Proceedings, 40:995 (1981).
Josso et al., C. R. Acad. Sc. Paris t. 293, 447-450 (1981).
Goding, J. W., Journal of Immunological Methods, 39:285-308 (1980).
Milstein, C., Monoclonal Antibodies, pp. 66-74.
Fuller et al., Gynecologic Oncology, 17:124-132 (1984).
Swann et al., Developmental Biology, 69:73-84 (1979).
Josso, N., Endo., 94:829-834 (1973).
Donahoe et al., Pediatric Andrology, pp. 37-46 (1981).
Biotechnology Newswatch, vol. 6, No. 12, pp. 1-2 (1986).

Affiliated with

Also associated with

Rating

Use of mullerian inhibiting substance as a contraceptive agent does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of mullerian inhibiting substance as a contraceptive agent, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of mullerian inhibiting substance as a contraceptive agent will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1913727